The excessive and uncontrolled consumption of alcohol, which can culminate in the development of alcohol use disorder or ...

This 3-part series looks at the current evidence for the treatment of SUD, alcohol use disorder, and tobacco use disorder.

This 3-part series looks at the current evidence for the treatment of SUDs. Part 2 reviews the use of GLP-1 receptor agonists and alcohol use disorder.

Getty Images The limited treatment options available for alcohol use disorder emphasize the urgent need for more research into pharmacological therapies. While more research is needed, preclinical and ...

Emergency departments may be missing opportunities to identify and treat people for problem alcohol use. A new study ...

Pemvidutide is a novel, peptide-based GLP-1/glucagon dual receptor agonist. The Food and Drug Administration (FDA) has granted Fast Track designation to pemvidutide for the treatment of alcohol use ...

To help someone struggling with alcohol, offer non-judgmental words of encouragement, avoid chastising them, and actively ...

A substance use disorder (SUD) is a treatable, chronic disease characterized by a cluster of cognitive, behavioral and ...

Alcoholism is a mental health condition that can affect emotional, physical, and mental health — but professional treatment ...

Naltrexone can help people cut back on how much alcohol they drink but is best used alongside behavioral and psychosocial support programs. A pill that costs less than a dollar has been called the ...

Baclofen, a GABA B receptor agonist traditionally used as a muscle relaxant, has emerged as a promising pharmacological option in the management of Alcohol Use Disorder (AUD). By modulating inhibitory ...

As many forms of healthcare and addiction treatment move online to mitigate the spread of COVID-19, treatment for alcohol use disorder is no exception. Dr. William Sonestuhl, advisor for the Cornell ...